iPSC Derived NKs: Targeting Cancer with an Engineered, iPSC-Derived NK Cell

Dr. Kaufman presented the features and advantages of iPSC-derived NK cells versus NK cells derived from alternative sources. He also demonstrates the ability of these cells to eliminate both liquid and solid tumors without causing Graft Versus Host Disease (GVHD), and reviewed approaches for enhancing the potency of NK cells against tumors through genetic engineering of various targeting modalities.